
Lupin Limited has informed the Exchange regarding a press release dated November 21, 2023, titled "Lupin Receives Approval from U.S. FDA for Pitavastatin Tablets. ".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated November 21, 2023, titled "Lupin Receives Approval from U.S. FDA for Pitavastatin Tablets. ".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin